Dr Reddy’s, RDIF begin trials for COVID-19 vaccine Sputnik V in India

The clinical trials will include safety and immunogenicity study

They have received clearance from Central Drugs Laboratory, Kasauli

JSS Medical Research is the clinical research partner

Currently, 40,000 volunteers are taking part in Phase III of Sputnik V clinical trials

Share.

Comments are closed.

Exit mobile version